Suggested remit: To appraise the clinical and cost effectiveness of ticagrelor within its marketing authorisation for preventing stroke after previous acute ischaemic stroke or high-risk transient ischaemic attack.
Following on from information provided to NICE by the company in July 2022, the appraisal of Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack [ID2689] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.
- Status:
- Discontinued
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 2689
Project Team
- Project lead
- Michelle Adhemar
Email enquiries
If you have any queries please email scopingta@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 21 July 2023 | Discontinued. Following on from information provided to NICE by the company in July 2022, the appraisal of Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack [ID2689] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued. |
| 21 July 2022 | Suspended. As you will be aware, the Department for Health & Social Care has asked NICE to carry out a Single Technology Appraisal of Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack. For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes. |
| 05 January 2021 | Note added to the project documents |
| 03 September 2020 | In progress. Topic is in progress |
| 03 September 2020 | Note added to the project documents |
| 11 June 2020 - 09 July 2020 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual